Cibc Private Wealth Group, LLC Exelixis, Inc. Transaction History

Cibc Private Wealth Group, LLC

$51.4 Billion
Q2 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 694 shares of EXEL stock, worth $24,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

694

Previous 694 -0.0%

Holding current value

$24,643

Previous $16,000 6.25%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$20.17 - $23.93 $13,997 - $16,607	694 New	694 $16,000
Q2 2022 Aug 03, 2022	SELL	$17.44 - $23.16 $44,995 - $59,752	-2,580 Reduced 18.35%	11,482 $239,000
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $239,475 - $318,785	14,062 New	14,062 $319,000
Q4 2021 Feb 08, 2022	SELL	$15.84 - $21.88 $198,776 - $274,572	-12,549 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $63,423 - $82,255	-3,891 Reduced 23.67%	12,549 $266,000
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $25,830 - $36,780	-1,439 Reduced 8.05%	16,440 $299,000
Q1 2021 May 12, 2021	SELL	$20.53 - $25.22 $26,175 - $32,155	-1,275 Reduced 6.66%	17,879 $404,000
Q3 2020 Nov 03, 2020	BUY	$20.67 - $26.94 $395,913 - $516,008	19,154 New	19,154 $469,000
Q3 2020 Oct 29, 2020	SELL	$20.67 - $26.94 $404,987 - $527,835	-19,593 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $823 - $1,371	50 Added 0.26%	19,593 $465,000
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $282,591 - $426,037	19,543 New	19,543 $336,000
Q4 2019 Jan 30, 2020	SELL	$15.15 - $18.89 $312,559 - $389,719	-20,631 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$17.68 - $22.65 $39,850 - $51,053	2,254 Added 12.27%	20,631 $365,000
Q2 2019 Jul 31, 2019	BUY	$18.93 - $24.75 $74,186 - $96,995	3,919 Added 27.11%	18,377 $393,000
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $62,837 - $79,380	3,206 Added 28.49%	14,458 $344,000
Q4 2018 Feb 05, 2019	BUY	$13.65 - $21.8 $153,589 - $245,293	11,252 New	11,252 $221,000
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $33,882 - $47,824	-2,135 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$18.56 - $22.45 $649 - $785	-35 Reduced 1.61%	2,135 $46,000
Q1 2018 May 17, 2018	SELL	$22.15 - $31.89 $5,869 - $8,450	-265 Reduced 10.88%	2,170 $48,000
Q4 2017 Feb 12, 2018	BUY	$24.23 - $30.93 $59,000 - $75,314	2,435	2,435 $74,000

Others Institutions Holding EXEL

# of Institutions

468

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Exelixis, Inc. Transaction History